Le Lézard
Classified in: Health, Business
Subject: ERP

Nolato: Very Strong Quarter for all Business Areas


TOREKOV, Sweden, July 19, 2018 /PRNewswire/ --

Today's report by Nolato for the second quarter of 2018 shows a continued very strong performance.

Adjusted for currency, sales for the Group increased by a very strong 34%.

Medical Solutions sales rose to SEK 562 million (498), which, adjusted for currency, is a strong increase of 10%. Operating profit (EBITA) was SEK 73 million (64), with an EBITA margin of 13.0% (12.9).

"Volumes increased in both the Medical Devices and Pharma Packaging sectors, but especially in Medical Devices in which the ramp-up of new customer projects made a positive contribution," noted Nolato's President and CEO, Christer Wahlquist.

Integrated Solutions sales rose to SEK 1,186 million (692); adjusted for currency, the increase was an exceptionally strong 66%. Operating profit (EBITA) rose to SEK 140 million (73) and the EBITA margin to a very strong 11.8% (10.5).

"Very high volumes were supplied in the quarter for the vaporiser heating products (VHP) product area," commented Christer Wahlquist. "Heating devices in particular enjoyed high launch volumes and inventory build-up at customers. In the second half of 2018, end-customer demand is expected to account for the majority of volumes at a persistently high level, although lower than in the second quarter, which was positively affected by both launches and inventory build-up. Mobile phone volumes remained relatively weak in the quarter."

Industrial Solutions sales amounted to SEK 554 million (489); adjusted for currency, sales increased by a very strong 12%. Operating profit (EBITA) increased to SEK 55 million (48), while the EBITA margin was 9.9% (9.8).

"Volumes have developed well across almost all product areas, particularly automotive and hygiene," noted Christer Wahlquist.

The Integrated Solutions business area is set to launch production in Suzhou in the second half of the year in order to transfer parts of production from Beijing. The new establishment will broaden Nolato's geographical presence, and help the company gain greater flexibility and diversification.

Nolato's financial position remains strong. Cash flow, including non-recurring items, increased to SEK 352 million (28). The equity/assets ratio was 43% (40) and net financial assets amounted to SEK 62 million (net liabilities of SEK ?639 million).

Nolato is a Swedish group with operations in Europe, Asia and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, consumer electronics, telecom, automotive, hygiene and other selected industrial sectors. Nolato's shares are listed on Nasdaq Stockholm in the Mid Cap segment, where they are included in the Industrials sector.

This information is information that Nolato AB is obliged to publish pursuant to the EU Market Abuse Regulation and the Swedish Securities Market Act. This information was released, through the provision of the above-mentioned contact persons, for publication on 19 July 2018, at 2.30 pm CET.

www.nolato.com

CONTACT:

For further information, please contact:

Christer Wahlquist, President and CEO, on +46-(0)-705-804848

Per-Ola Holmström, CFO, on +46-(0)-705-763340

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/nolato/r/very-strong-quarter-for-all-business-areas,c2578264

The following files are available for download:

http://mb.cision.com/Main/966/2578264/880762.pdf

The complete report

http://mb.cision.com/Public/966/2578264/b0c0ffbb42e788e4.pdf

The release as PDF

SOURCE Nolato


These press releases may also interest you

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...



News published on and distributed by: